Northwestern Medicine investigators have uncovered new insights into how intercellular "glue" functions to enable ...

NEWTON, MA, USA I March 19, 2025 I Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that ...

Capricor presented preclinical data at the 2024 American Association of Extracellular Vesicles (AAEV) Annual Meeting. The ...

Today's Marketplace (TMP) is proud to announce a featured interview with Acumen Pharmaceuticals (NASDAQ: ABOS) CEO Daniel ...

BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that the US FDA Office of Orphan Products Development (OOPD) has granted ...

ProMIS Neurosciences (PMN) announced that the Company will present preclinical data on computationally-derived vaccines for neurodegenerative ...

As viral vaccines are increasingly used to meet global health needs, the pharmaceutical industry is manufacturing larger ...

PMN310, the Company’s lead product candidate for the treatment of AD, is a differentiated, humanized monoclonal antibody that ...

The live webcasts may be accessed under the Investors tab on www.acumenpharm.com and will be archived for 90 days.

The New Mexico Office of the Medical Investigator says Hackman died from a cardiovascular disease with Alzheimer's being a contributing factor. Sign up for our Newsletters The Alzheimer's Association ...

The following resolution were passed at the extraordinary general meeting (the "EGM") of Alzinova AB (publ) ("the Company") on 7 March 2025 in Gothenburg. Long-term incentive program (LTIP 2025:1 for ...